Home > Healthcare > Medical Devices > Therapeutic Devices > Stroke Management Market

Stroke Management Market Analysis

  • Report ID: GMI3550
  • Published Date: Nov 2022
  • Report Format: PDF

Stroke Management Market Analysis

On the basis of type, the industry is categorized into hemorrhagic, ischemic, transient ischemic attack, and others. Amongst them, the market share from transient ischemic attack (TIA) segment is projected to surpass USD 1.5 billion by 2032. The segment outlook is fuelled by the increasing mortality rate associated with the disease, which is fostering the adoption of stroke management devices. In addition, the rising inclination towards catheter-based devices for interventional procedures to remove thrombi is also poised to accelerate market statistics. 
 

 

On the basis of product, the market is bifurcated into therapeutic devices and diagnostic devices. The therapeutic devices segment is expected to surpass USD 11.5 billion by 2032. Segmental growth is slated to be driven by the increasing number of patients suffering from an aneurysm. As per the Brain Aneurysm Foundation, ruptured brain aneurysms are responsible for 3-5% of all new stroke cases. To that end, increasing use of therapeutic devices such as surgical clipping is also likely to outline the segment outlook. 
 

 

Stroke Management Market, by End-use

With respect to end-use, stroke management market is segmented into ambulatory surgery centers, diagnostic centers, hospitals, and others. The hospital segment accounted for over 39% market share in 2022. The segment is forecast to depict strong growth owing to increasing hospital admissions, which are in-turn driven by the increasing accessibility to favorable reimbursement policies for treatment procedures performed in hospital settings. As per the American Hospital Association, in 2022, over 33.3 million heart attack and stroke patients were hospitalized in the U.S. alone.
 

 

Stroke Management Market, by Region

Asia Pacific stroke management market share is expected to surpass USD 17 billion by 2032. Increasing investments from both public as well as private organizations towards initiatives that are designed to spread more awareness about cardiovascular ailments will drive regional market share. Meanwhile, growing efforts from leading regional industry players towards capturing a higher market share in emerging Asia-Pacific nations will also define segment expansion.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for stroke management held a valuation of over USD 37 billion in 2022 and is poised to grow at 6% CAGR between 2023 and 2032.

APAC market for stroke management is poised to surpass USD 17 billion by 2032, driven by rising public and private sector spending on generating awareness about cardiovascular disorders and the rising market player focus on emerging Asia-Pacific countries.

The transient ischemic attack (TIA) segment is expected to cross USD 1.5 billion by 2032, fueled by escalating the adoption of stroke management devices and growing preference for catheter-based devices for interventional procedures.

Some of the leading market players include Asahi Intecc CO., LTD, GE Healthcare, Abbott, Johnson & Johnson, Medtronic, Boston Scientific Corporation, Penumbra, Inc., among others.

Stroke Management Market Scope

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2022
  • Companies covered: 14
  • Tables & Figures: 381
  • Countries covered: 25
  • Pages: 280
 Download Free Sample